Literature DB >> 19717198

A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapy.

Kiran Devisetty1, Loren K Mell, Joseph K Salama, David A Schomas, Robert C Miller, Ashesh B Jani, John C Roeske, Bulent Aydogan, Steven J Chmura.   

Abstract

Using previous dosimetric analysis methods, we identified the volume of bowel receiving 30 Gy (V(30)) correlated with acute gastrointestinal (GI) toxicity in anal cancer patients treated with intensity-modulated radiation therapy and concurrent chemotherapy. For V(30)>450 cc and < or =450 cc, acute GI toxicity was 33% and 8%, respectively (p=0.003).

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19717198     DOI： 10.1016/j.radonc.2009.07.006

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


  25 in total

Review 1.  Advances in the Management of Anal Cancer.

Authors:  Diana R Julie; Karyn A Goodman
Journal:  Curr Oncol Rep       Date:  2016-03       Impact factor: 5.075

2.  HIV- positive anal cancer: an update for the clinician.

Authors:  Savita V Dandapani; Michael Eaton; Charles R Thomas; Paul G Pagnini
Journal:  J Gastrointest Oncol       Date:  2010-09

3.  Management of Stage I Squamous Cell Carcinoma of the Anal Canal.

Authors:  Christy Y Chai; Hop S Tran Cao; Samir Awad; Nader N Massarweh
Journal:  JAMA Surg       Date:  2018-03-01       Impact factor: 14.766

4.  Concurrent chemoradiation with volumetric modulated Arc therapy of patients treated for anal cancer-acute toxicity and treatment outcome.

Authors:  Kaloyan Yordanov; Simona Cima; Antonella Richetti; Gianfranco Pesce; Francesco Martucci; Ngwa Che Azinwi; Maria Carla Valli
Journal:  J Gastrointest Oncol       Date:  2017-04

5.  Radiotherapy with or without chemotherapy in the treatment of anal cancer: 20-year experience from a single institute.

Authors:  K Fakhrian; T Sauer; S Klemm; C Bayer; B Haller; M Molls; H Geinitz
Journal:  Strahlenther Onkol       Date:  2012-11-15       Impact factor: 3.621

Review 6.  Technical aspects of radiation therapy for anal cancer.

Authors:  Eli D Scher; Inaya Ahmed; Ning J Yue; Salma K Jabbour
Journal:  J Gastrointest Oncol       Date:  2014-06

7.  Predictors of acute gastrointestinal toxicity during pelvic chemoradiotherapy in patients with rectal cancer.

Authors:  T Jonathan Yang; Jung Hun Oh; Christina H Son; Aditya Apte; Joseph O Deasy; Abraham Wu; Karyn A Goodman
Journal:  Gastrointest Cancer Res       Date:  2013-09

8.  Dosimetric and clinical toxicity comparison of critical organ preservation with three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, and RapidArc for the treatment of locally advanced cancer of the pancreatic head.

Authors:  L Jin; R Wang; S Jiang; J Yue; T Liu; X Dou; K Zhu; R Feng; X Xu; D Chen; Y Yin
Journal:  Curr Oncol       Date:  2016-02-18       Impact factor: 3.677

9.  Plan comparison of volumetric-modulated arc therapy (RapidArc) and conventional intensity-modulated radiation therapy (IMRT) in anal canal cancer.

Authors:  Sabine Vieillot; David Azria; Claire Lemanski; Carmen Llacer Moscardo; Sophie Gourgou; Jean-Bernard Dubois; Norbert Aillères; Pascal Fenoglietto
Journal:  Radiat Oncol       Date:  2010-10-13       Impact factor: 3.481

10.  Reduced radiation dose for elective nodal irradiation in node-negative anal cancer: back to the roots?

Authors:  Christoph Henkenberens; Daniela Meinecke; Stoll Michael; Michael Bremer; Hans Christiansen
Journal:  Strahlenther Onkol       Date:  2015-08-26       Impact factor: 3.621
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.